Through the Equity Initiative, our Fellows from Southeast Asia and China gain a deeper understanding of health equity concepts and practices, examine approaches to enhancing equity from other parts of Asia and the world, build up their leadership skills, and develop new ideas they can apply in their own work. Reflection is an integral part of the Equity Initiative experience, and several Fellows recently shared their reflections on how EI has become a source of inspiration for them. Read more.

CMB has initiated support for a postdoctoral research fellowship program that will give U.S. scholars from the health professions and biomedical sciences an opportunity to spend 1-2 years at selected academic and medical universities in China. In partnership with three U.S. academic health science centers, the CMB Postdoctoral Research Program in China aims to build on U.S. and China common interests in advancing public health and biomedical research, while creating a pathway for American researchers to build longer-term collaborative partnerships with their Chinese counterparts. Read more.

Peking Union Medical College Hospital (PUMCH) has become a leader nationally in advancing the study and treatment of rare diseases. Zhang Shuyang, MD, PhD, the first female president of PUMCH and concurrently vice president of the Chinese Academy of Medical Sciences and Peking Union Medical College, has played a pivotal role in establishing PUMCH’s preeminence in this field. For two decades, she has propelled China’s rare disease agenda forward through coordination with key stakeholders, leveraging resources, promoting new approaches to clinical diagnosis and treatment, and facilitating research and industry collaboration. Read more